AKEEGA - Administration via a Feeding Tube

Summary

• Johnson & Johnson cannot recommend any practices, procedures, handling, or dosage and administration techniques that deviate from the approved product labeling.
• AKEEGA is not commercially available as a solution or suspension.
• Data from pharmacokinetic (PK) and pharmacodynamic (PD) studies of crushing, splitting, or dispersion of AKEEGA tablets for administration, have not been published.
• Data on the administration of AKEEGA tablets via a feeding tube (e.g., nasogastric tube [NG-tube], gastric tube [G-tube], jejunal tube [J-tube]) have not been published.

CLINICAL DATA

No relevant clinical study information was identified for the administration of AKEEGA tablets via a feeding tube.

LITERATURE SEARCH

A literature search of MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File (and/or other resources, including internal/external databases) conducted on 27 May 2026 did not identify any relevant citations pertaining to this topic in patients with prostate cancer.